These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 37188987)

  • 41. Computer-Aided Color Parameter Imaging of Contrast-Enhanced Ultrasound Evaluates Hepatocellular Carcinoma Hemodynamic Features and Predicts Radiofrequency Ablation Outcome.
    Wang H; Guo W; Yang W; Liu G; Cao K; Sun Y; Liang ZN; Bai XM; Wang S; Wu W; Yan K; Goldberg SN
    Ultrasound Med Biol; 2022 Aug; 48(8):1555-1566. PubMed ID: 35597704
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Image-guided radiofrequency ablation of hepatocellular carcinoma (HCC): is MR guidance more effective than CT guidance?
    Clasen S; Rempp H; Hoffmann R; Graf H; Pereira PL; Claussen CD
    Eur J Radiol; 2014 Jan; 83(1):111-6. PubMed ID: 24161781
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pretreatment prediction of immunoscore in hepatocellular cancer: a radiomics-based clinical model based on Gd-EOB-DTPA-enhanced MRI imaging.
    Chen S; Feng S; Wei J; Liu F; Li B; Li X; Hou Y; Gu D; Tang M; Xiao H; Jia Y; Peng S; Tian J; Kuang M
    Eur Radiol; 2019 Aug; 29(8):4177-4187. PubMed ID: 30666445
    [TBL] [Abstract][Full Text] [Related]  

  • 44. SQSTM1 Expression in Hepatocellular Carcinoma and Relation to Tumor Recurrence After Radiofrequency Ablation.
    Abdel-Moety A; Baddour N; Salem P; El-Tobgy H; El-Shendidi A
    J Clin Exp Hepatol; 2022; 12(3):774-784. PubMed ID: 35677515
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recent Advances in Tumor Ablation for Hepatocellular Carcinoma.
    Kang TW; Rhim H
    Liver Cancer; 2015 Sep; 4(3):176-87. PubMed ID: 26674766
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fusion imaging with contrast-enhanced ultrasonography for evaluating the early therapeutic efficacy of radiofrequency ablation for small hypervascular hepatocellular carcinomas with iso-echoic or unclear margins on conventional ultrasonography.
    Nishigori S; Numata K; Irie K; Fukuda H; Chuma M; Maeda S
    J Med Ultrason (2001); 2018 Jul; 45(3):405-415. PubMed ID: 29362966
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Guideline-based thermal ablation of hepatocellular carcinoma].
    Mahnken AH
    Radiologe; 2022 Mar; 62(3):219-224. PubMed ID: 35037979
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of combined Gd-EOB-DTPA and gadobutrol magnetic resonance imaging for the prediction of hepatocellular carcinoma grading.
    Schelhorn J; Best J; Dechêne A; Göbel T; Bertram S; Lauenstein T; Kinner S
    Acta Radiol; 2016 Aug; 57(8):932-8. PubMed ID: 26586852
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Predicting the Outcome of Transcatheter Arterial Embolization Therapy for Unresectable Hepatocellular Carcinoma Based on Radiomics of Preoperative Multiparameter MRI.
    Sun Y; Bai H; Xia W; Wang D; Zhou B; Zhao X; Yang G; Xu L; Zhang W; Liu P; Xu J; Meng S; Liu R; Gao X
    J Magn Reson Imaging; 2020 Oct; 52(4):1083-1090. PubMed ID: 32233054
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Radiomic Analysis Based on Magnetic Resonance Imaging for Predicting PD-L2 Expression in Hepatocellular Carcinoma.
    Tao YY; Shi Y; Gong XQ; Li L; Li ZM; Yang L; Zhang XM
    Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672315
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Real-time US-CT/MR fusion imaging for percutaneous radiofrequency ablation of hepatocellular carcinoma.
    Ahn SJ; Lee JM; Lee DH; Lee SM; Yoon JH; Kim YJ; Lee JH; Yu SJ; Han JK
    J Hepatol; 2017 Feb; 66(2):347-354. PubMed ID: 27650284
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effectiveness and safety in radiofrequency ablation of pulmonary metastases from HCC: a five years study.
    Lassandro G; Picchi SG; Bianco A; Di Costanzo G; Coppola A; Ierardi AM; Lassandro F
    Med Oncol; 2020 Mar; 37(4):25. PubMed ID: 32166529
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Microwave ablation is as effective as radiofrequency ablation for very-early-stage hepatocellular carcinoma.
    Xu Y; Shen Q; Wang N; Wu PP; Huang B; Kuang M; Qian GJ
    Chin J Cancer; 2017 Jan; 36(1):14. PubMed ID: 28103953
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Progress of MRI Radiomics in Hepatocellular Carcinoma.
    Gong XQ; Tao YY; Wu YK; Liu N; Yu X; Wang R; Zheng J; Liu N; Huang XH; Li JD; Yang G; Wei XQ; Yang L; Zhang XM
    Front Oncol; 2021; 11():698373. PubMed ID: 34616673
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Radiofrequency Ablation and Microwave Ablation in Liver Tumors: An Update.
    Izzo F; Granata V; Grassi R; Fusco R; Palaia R; Delrio P; Carrafiello G; Azoulay D; Petrillo A; Curley SA
    Oncologist; 2019 Oct; 24(10):e990-e1005. PubMed ID: 31217342
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Single-nodule hepatitis B virus-associated hepatocellular carcinoma smaller than 3 cm: two phenotypes defined by cluster analysis and their association with the outcome of ablation as the first-line therapy.
    Chen S; Wu Y; Qi H; Shen L; Ma W; Cao F; Diao Y; Wang T; Ou S; Fan W
    Int J Hyperthermia; 2021; 38(1):120-129. PubMed ID: 33541160
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of efficacy of transcatheter arterial chemoembolization combined with computed tomography-guided radiofrequency ablation for hepatocellular carcinoma using magnetic resonance diffusion weighted imaging and computed tomography perfusion imaging: A prospective study.
    Shao GL; Zheng JP; Guo LW; Chen YT; Zeng H; Yao Z
    Medicine (Baltimore); 2017 Jan; 96(3):e5518. PubMed ID: 28099329
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Thermal ablation for hepatocellular carcinoma: what's new in 2019.
    Zhu F; Rhim H
    Chin Clin Oncol; 2019 Dec; 8(6):58. PubMed ID: 31968982
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Imaging Modalities for Assessment of Treatment Response to Nonsurgical Hepatocellular Carcinoma Therapy: Contrast-Enhanced US, CT, and MRI.
    Minami Y; Kudo M
    Liver Cancer; 2015 Mar; 4(2):106-14. PubMed ID: 26697413
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rate of local tumor progression following radiofrequency ablation of pathologically early hepatocellular carcinoma.
    Hao Y; Numata K; Ishii T; Fukuda H; Maeda S; Nakano M; Tanaka K
    World J Gastroenterol; 2017 May; 23(17):3111-3121. PubMed ID: 28533668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.